The new AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary offers advice regarding surveillance intervals using endoscopy and other relevant modalities after endoscopic removal of dysplastic legions and early GI cancers with endoscopic submucosal dissection (ESD) which were deemed pathologically curative.
Patients with malignant legions removed by curative ESD possess a higher risk of lymph node metastasis that should be surveilled more closely than those with resection dysplasia not associated with lymphatic spread.
In the short video below, lead author Andrew Y. Wang, MD, AGAF, advanced endoscopist at the University of Virginia and chair of the AGA Clinical Practice Updates Committee, shares key findings from the commentary.
Read the full commentary AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States in Gastroenterology.
